XPO1 inhibitors represent a novel therapeutic option in Adult T-cell Leukemia, triggering p53-mediated caspase-dependent apoptosis.
作者信息
Boons Eline, Nogueira Tatiane C, Dierckx Tim, Menezes Soraya Maria, Jacquemyn Maarten, Tamir Sharon, Landesman Yosef, Farré Lourdes, Bittencourt Achiléa, Kataoka Keisuke, Ogawa Seishi, Snoeck Robert, Andrei Graciela, Van Weyenbergh Johan, Daelemans Dirk
机构信息
KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Virology and Chemotherapy, Rega Institute, B-3000, Leuven, Belgium.
KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Clinical and Epidemiological Virology, Rega Institute, B-3000, Leuven, Belgium.
出版信息
Blood Cancer J. 2021 Feb 1;11(2):27. doi: 10.1038/s41408-021-00409-3.
Abstract
摘要
Zotero 插件